Abel Ang

Mr. Abel Ang is the Group Chief Executive Officer of Accuron MedTech, where he has overall responsibility for Accuron’s Medical Device activities.

Abel has a proven track record in the medical device sector. He has served as the Senior Advisor to the CEO of Greatbatch Inc (NYSE:GB), providing guidance relative to the commercialization of medical device technologies in the cardiac, neurology, vascular and orthopedic markets. Prior to Greatbatch, Abel was President, Asia/Pacific for Hill-Rom Inc. a US$1.7B revenue medical devices company (NYSE: HRC) where he was responsible for leading, developing, and implementing the strategy to expand Hill-Rom’s presence in the Asia/Pacific markets. He formerly served as the Chief Technology Officer for Hill-Rom for 3 years. In that role, he had overall responsibility for Hill-Rom’s global R&D operations which are distributed across sites in the U.S., Mexico, France, and Singapore. At Hill-Rom, he also held the positions of Vice-President and General Manager of Hill-Rom’s US$420MM Global Surfaces and Therapy Business Unit; and Vice-President for International Business and Technology Development. He formerly headed the global Medical Technology and Biotechnology industry groups in the Singapore Economic Development Board’s (EDB) Biomedical Division.